M K Proteins financials

·FMCG & RetailChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹115cr+0.2% on Q1 FY26
Net profit
₹1.4cr−60.7% on Q1 FY26
EBITDA margin
2.2%−2.6 pts on Q1 FY26
EPS
₹0.04−55.6% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue115115+0.2%
EBITDA2.55.5−54.4%
EBITDA margin2.2%4.8%−2.6 pts
Profit before tax1.84.7−60.7%
Net profit1.43.5−60.7%
EPS₹0.04₹0.09−55.6%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹115 crNet profit₹1.4 crNet margin1.2%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024
137———
0.40.40.00.1
36.236.237.819.1
173———
383383268246
—+43.0%+9.0%—
8.411.412.416.6
2.2%3.0%4.6%6.8%
7.911.012.116.1
4.76.88.411.2
1.2%1.8%3.1%4.6%
₹0.13₹0.18₹0.22₹0.30
—−18.7%−25.1%—
—5.4−16.132.4
—−1.9−2.2−5.9
3.53.5−18.426.5
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

MKPL₹3.65

M K Proteins Limited

· FMCG & Retail
₹ CrorePeersROMLHALDERNKINDGOKULKRITINUTSUNDROPMcap ₹137 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization———137.0
- Cash, Equiv & ST Investments0.10.00.40.4
+ Total Debt19.137.836.236.2
Enterprise Value———172.8
Revenue245.6267.7382.9383.1
Growth %, YoY—+9.0+43.0—
EBITDA16.612.411.48.4
Margin %6.774.642.982.20
EBIT16.112.111.07.9
Net Income11.28.46.84.7
Margin %4.573.141.781.23
EPS, Adj (current shares)0.300.220.180.13
Growth %, YoY—-25.1-18.7—
Cash from Operations32.4-16.15.4—
Capital Expenditures-5.9-2.2-1.9—
Free Cash Flow26.5-18.43.53.5
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

M K Proteins financials and key ratios

Prices at the 30 October 2026 close · figures from the company's filings with NSE

M K Proteins (NSE: MKPL) had a market capitalisation of ₹139 crore at the 30 October 2026 close (₹3.69 a share), a PE ratio of 29.5 on the last four quarters' profit and a price-to-book ratio of 1.82. In FY26 its consolidated net profit was ₹6.8 crore on revenue of ₹383 crore; in Q1 FY27 (April–June 2026) it was ₹1.4 crore, down 60.7% year on year. Its debt-to-equity ratio was 0.47 on 31 March 2026. Promoters held 74.82% of the shares on 30 September 2026.

M K Proteins Q1 FY27 results
filed 13 August 2026
Share price used
₹3.69 · 30 October 2026 close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026

M K Proteins at a glance · consolidated

Market cap
₹139 Crat ₹3.69 · 30 Oct close
PE ratio (last 4 quarters)
29.520.3 on FY26 profit
Price to book (PB)
1.82book value ₹2.03 a share
ROE (FY26)
9.4%−3.5 pts vs FY25ROCE 14.6%
Debt to equity
0.47net debt ₹35.8 Cr
Promoter holding
74.82%unchanged vs 30 Jun 202630 September 2026
Net worth
₹76.3 Cr+9.8% vs 31 Mar 202531 March 2026
Free cash flow (FY26)
₹3.5 Cr
EPS (FY26)
₹0.18

Questions

What is the M K Proteins PE ratio today?

M K Proteins' PE ratio is 29.5 at the 30 October 2026 close (₹3.69 a share): a market capitalisation of ₹139 crore divided by consolidated net profit of ₹4.7 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹6.8 crore) it is 20.3.

What is the M K Proteins net worth?

M K Proteins' net worth — shareholders' equity in its consolidated balance sheet — was ₹76.3 crore on 31 March 2026, up 9.8% from ₹69.5 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹139 crore at the 30 October 2026 close.

What is the M K Proteins book value per share?

M K Proteins' book value per share was ₹2.03 on 31 March 2026: shareholders' equity of ₹76.3 crore divided by the 37.54 crore shares in issue, up 9.8% from ₹1.85 a year earlier. The share price at the 30 October 2026 close was ₹3.69.

What is the M K Proteins PB ratio (price to book value)?

M K Proteins' price-to-book (PB) ratio is 1.82 at the 30 October 2026 close: a market capitalisation of ₹139 crore divided by shareholders' equity (book value) of ₹76.3 crore on 31 March 2026. That is a book value of ₹2.03 per share against a share price of ₹3.69.

What is the M K Proteins ROE and ROCE?

In FY26, M K Proteins' return on equity (ROE) was 9.4% and its return on capital employed (ROCE) was 14.6%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 12.9% and ROCE 18.1%.

What is the M K Proteins free cash flow?

In FY26, M K Proteins generated ₹5.4 crore of cash from operations and spent ₹1.9 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹3.5 crore. In FY25 it was −₹18.4 crore.

What is the M K Proteins market cap?

M K Proteins' market capitalisation was ₹139 crore at the 30 October 2026 close: 37.54 crore shares at ₹3.69 each.

What is the M K Proteins EPS?

M K Proteins' basic earnings per share (EPS) were ₹0.18 in FY26, against ₹0.22 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹0.13.

What is the M K Proteins shareholding pattern?

On 30 September 2026, M K Proteins' shares were held by promoters 74.82% and retail and other non-institutional investors 25.18%.

Is M K Proteins debt free?

No. M K Proteins had borrowings of ₹36.2 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.47. Its cash and current investments were ₹44 lakh, so its net debt was ₹35.8 crore.

What is the M K Proteins debt to equity ratio?

M K Proteins' debt-to-equity ratio was 0.47 on 31 March 2026: borrowings of ₹36.2 crore against total equity of ₹76.3 crore. A year earlier, on 31 March 2025, it was 0.54.

What is the M K Proteins promoter holding?

Promoters held 74.82% of M K Proteins on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.

What are the M K Proteins latest quarterly results?

M K Proteins' latest results are for Q1 FY27 (April–June 2026), filed on 13 August 2026: consolidated net profit ₹1.4 crore, down 60.7% from ₹3.5 crore in Q1 FY26; revenue from operations ₹115 crore, up 0.2% year on year.

What is the M K Proteins revenue and profit in FY26?

In FY26 (April 2025–March 2026), M K Proteins' consolidated net profit was ₹6.8 crore, down 18.7% from ₹8.4 crore in FY25, on revenue from operations of ₹383 crore (up 43.0%).

How does M K Proteins compare with its peers?

On FY26 consolidated figures, against Raj Oil Mills, Halder Venture and NK Industries: M K Proteins' operating margin of 2.9% is the third highest of the four (Raj Oil Mills 3.6%, Halder Venture 3.4%, NK Industries −33.2%; peer average −8.7%).

When are the M K Proteins next results?

M K Proteins has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.

M K Proteins vs Raj Oil Mills: how do they compare?

In FY26, M K Proteins earned net profit of ₹6.8 crore on revenue of ₹383 crore, against ₹4.7 crore on ₹151 crore for Raj Oil Mills. M K Proteins' operating margin was 2.9% (Raj Oil Mills 3.6%) and its return on equity 9.4% (Raj Oil Mills −3,248.4%). At the 30 October 2026 close, M K Proteins' market capitalisation was ₹139 crore against ₹59.2 crore for Raj Oil Mills, and its PE ratio on FY26 profit 20.3 against 12.7.

Where do these M K Proteins figures come from?

From M K Proteins' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.